X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
1 expression (1) 1
acetylation (1) 1
adult (1) 1
aged (1) 1
aged, 80 and over (1) 1
apoptosis (1) 1
biomarkers, tumor - analysis (1) 1
breast cancer (1) 1
cancer-cells (1) 1
cell cycle (1) 1
cell growth (1) 1
cell proliferation (1) 1
chromatin (1) 1
clinicopathological parameters (1) 1
diabetes (1) 1
disease-free survival (1) 1
ductal adenocarcinoma (1) 1
enzymes (1) 1
epigenetic inheritance (1) 1
epigenetics (1) 1
expression analysis (1) 1
female (1) 1
gene expression (1) 1
genetic engineering (1) 1
growth (1) 1
hdac (1) 1
histone deacetylase 1 - analysis (1) 1
histone deacetylase 2 - analysis (1) 1
histone deacetylases - analysis (1) 1
human hepatocellular-carcinoma (1) 1
humans (1) 1
immunoglobulins (1) 1
immunohistochemistry (1) 1
index medicus (1) 1
kaplan-meier estimate (1) 1
liver cancer (1) 1
maintenance (1) 1
male (1) 1
medical prognosis (1) 1
middle aged (1) 1
mitosis (1) 1
multivariate analysis (1) 1
neoplasm grading (1) 1
neuroendocrine tumors - enzymology (1) 1
neuroendocrine tumors - mortality (1) 1
neuroendocrine tumors - pathology (1) 1
neuroendocrine tumors - therapy (1) 1
overall survival (1) 1
pancreatic neoplasms - enzymology (1) 1
pancreatic neoplasms - mortality (1) 1
pancreatic neoplasms - pathology (1) 1
pancreatic neoplasms - therapy (1) 1
pancreatic neuroendocrine tumor (1) 1
pathology (1) 1
patient outcomes (1) 1
predictive value of tests (1) 1
progression (1) 1
proliferation (1) 1
risk factors (1) 1
rodents (1) 1
sirtuin 1 - analysis (1) 1
statistical analysis (1) 1
studies (1) 1
survival analysis (1) 1
time factors (1) 1
tumorigenesis (1) 1
tumors (1) 1
up-regulation (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Pathology, ISSN 0046-8177, 2017, Volume 65, pp. 41 - 52
Epigenetic factors contribute to carcinogenesis, tumor promotion and chemoresistance. Histone deacetylases (HDACs) are epigenetic regulators that primarily... 
Pathology | Expression analysis | Proliferation | Overall survival | Disease-free survival | HDAC | Pancreatic neuroendocrine tumor | CANCER-CELLS | DUCTAL ADENOCARCINOMA | ACETYLATION | PATHOLOGY | MAINTENANCE | CLINICOPATHOLOGICAL PARAMETERS | GROWTH | 1 EXPRESSION | HUMAN HEPATOCELLULAR-CARCINOMA | PROGRESSION | Immunohistochemistry | Histone Deacetylases - analysis | Predictive Value of Tests | Up-Regulation | Cell Proliferation | Histone Deacetylase 2 - analysis | Mitosis | Humans | Middle Aged | Male | Neuroendocrine Tumors - enzymology | Neoplasm Grading | Time Factors | Aged, 80 and over | Adult | Female | Pancreatic Neoplasms - mortality | Neuroendocrine Tumors - pathology | Sirtuin 1 - analysis | Biomarkers, Tumor - analysis | Pancreatic Neoplasms - pathology | Risk Factors | Kaplan-Meier Estimate | Pancreatic Neoplasms - enzymology | Disease-Free Survival | Histone Deacetylase 1 - analysis | Neuroendocrine Tumors - mortality | Aged | Neuroendocrine Tumors - therapy | Pancreatic Neoplasms - therapy | Epigenetic inheritance | Chromatin | Genetic engineering | Patient outcomes | Tumors | Enzymes | Immunoglobulins | Statistical analysis | Breast cancer | Multivariate analysis | Gene expression | Studies | Liver cancer | Survival analysis | Cell growth | Medical prognosis | Rodents | Cell cycle | Epigenetics | Tumorigenesis | Diabetes | Apoptosis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.